Evidence map›Paper›PMID 23089886›Full record

ArticleClinical hemorheology and microcirculation2014

Effects of ethanol on red blood cell rheological behavior.

M Rabai, J A Detterich, R B Wenby, K Toth, H J Meiselman

Open access · greenAbstract read
In one paragraph

Article in Clinical hemorheology and microcirculation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Red blood cell components: time to revisit the sources of variability.Blood transfusion = Trasfusione del sangue · 2017
    Review
  8. The role of hemorheological factors in cardiovascular medicine.Clinical hemorheology and microcirculation · 2014
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

M Rabai1st Department of Medicine, University of Pecs, School of Medicine, Pecs, Hungary Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
J A DetterichDepartment of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
R B WenbyDepartment of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
K Toth1st Department of Medicine, University of Pecs, School of Medicine, Pecs, Hungary.
H J MeiselmanDepartment of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
University of Pecs · HUUniversity of Southern California · USChildren's Hospital of Los Angeles · US

Funding

ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAIA, JOHN A · 1985 to 2010
$76.4M
Neuromodulatory Mechanisms and Regional Autonomic Dysregulation in the Development of Pain in Sickle Cell Disease PatientsU01HL117718 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI COATES, THOMAS DUANE, KHOO, MICHAEL C K · 2013 to 2017
$9.6M
Childrens Hospital Los Angeles Child Health Research Development AwardK12HD052954 · NICHD · CHILDREN'S HOSPITAL OF LOS ANGELES · PI WILLIAMS, ROBERTA GAY · 2006 to 2017
$4.0M
SICKLE CELL CENTERP60HL048484 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JOHNSON, CAGE S · 1993 to 2002
$3.9M
Iron-mediated vascular disease in sickle cell disease.RC1HL099412 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI WOOD, JOHN C · 2009 to 2010
$995k
NCRR NIH HHS M01 RR000043NHLBI NIH HHS HL099412NHLBI NIH HHS HL48484NHLBI NIH HHS RC1 HL099412NHLBI NIH HHS U01 HL117718NICHD NIH HHS K12 HD052954
6 · The paper itself

Abstract

Consumption of red wine is associated with a decreased risk of several cardiovascular diseases (e.g., coronary artery disease, stroke), but unfortunately literature reports regarding ethanol's effects on hemorheological parameters are not concordant. In the present study, red blood cell (RBC) deformability was tested via laser ektacytometry (LORCA, 0.3-30 Pa) using two approaches: 1) addition of ethanol to whole blood at 0.25%-2% followed by incubation and testing in ethanol-free LORCA medium; 2) addition of ethanol to the LORCA medium at 0.25%-6% then testing untreated native RBC in these media. The effects of ethanol on deformability for oxidatively stressed RBC were investigated as were changes of RBC aggregation (Myrenne Aggregometer) for cells in autologous plasma or 3% 70 kDa dextran. Significant dose-related increases of RBC deformability were observed at 0.25% (p < 0.05) and higher concentrations only if ethanol was in the LORCA medium; no changes occurred for cells previously incubated with ethanol then tested in ethanol-free medium. The impaired deformability of cells pre-exposed to oxidative stress was improved only if ethanol was in the LORCA medium. RBC aggregation decreased with concentration at 0.25% and higher for cells in both autologous plasma and dextran 70. Our results indicate that ethanol reversibly improves erythrocyte deformability and irreversibly decreases erythrocyte aggregation; the relevance of these results to the health benefits of moderate wine consumption require further investigation.

Indexed as

WineAdultCardiovascular DiseasesErythrocyte AggregationErythrocyte DeformabilityErythrocytesEthanolHumansOxidative StressEthanolAlcoholerythrocyte aggregationerythrocyte deformabilityoxidative stress

Identifiers

PMID23089886
PMCPMC4940038
OpenAlexW32987333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.